Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Abstract Proprotein convertase subtilisin/kexin type 9 (PCSK9) has evolved as a pivotal enzyme in lipid metabolism and a revolutionary therapeutic target for hypercholesterolemia and its related cardiovascular diseases (CVD). This comprehensive review delineates the intricate roles and wide-ranging...

Full description

Bibliographic Details
Main Authors: Xuhui Bao, Yongjun Liang, Hanman Chang, Tianji Cai, Baijie Feng, Konstantin Gordon, Yuekun Zhu, Hailian Shi, Yundong He, Liyi Xie
Format: Article
Language:English
Published: Nature Publishing Group 2024-01-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-023-01690-3

Internet

https://doi.org/10.1038/s41392-023-01690-3

Similar Items